200 per cent returns in just six months: Board announced bonus shares and annual results!

The company has reported 55 per cent jump in net profit of the company in FY23.

Infinium Pharmachem Limited informed in the exchange filing that it called and convened the Annual General Meeting held on Monday, August 28, 2023. The following businesses mentioned in the Notice of the AGM were discussed as follows: The approval for an increase in the authorised share capital of the company and the alteration of the capital clause of the memorandum of association of the company. The approval of bonus issue to the shareholders of the company was also given.

In FY23, the company posted strong Quarterly Results. The revenue of the company for FY23 stood at Rs 114.23 crore which grew by 15.24 per cent on a YoY basis. The operating profit of the company stood at Rs 17.40 crore which grew by 58.64 per cent on a YoY basis, while the PAT of the company stood at Rs 9.82 crore, representing an impressive growth of 46.81 per cent YoY.

Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs. Infinium is an integrated Pharma and Healthcare segment company with niche products. Co. manufactures and supplies various pharma-related chemicals, bulk drugs, pharma intermediates, etc.

Infinium Pharmachem Limited have delivered multibagger returns to its shareholders in the last six months. During this period, shares of Infinium Pharmachem surged from Rs 147.80 on April 17, 2023, to Rs 511.15 on September 01, 2023, an increase of about 240 per cent.

Disclaimer: The article is for informational purposes only and not investment advice.